ClinicalTrialsFinder

KRAS G12S Mutation Clinical Trials in Oklahoma City, Oklahoma

1 recruitingOklahoma City, Oklahoma

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Solid Tumor MalignanciesCRC (Colorectal Cancer)KRAS G12C Mutation+1 more
Kumquat Biosciences Inc.140 enrolled11 locationsNCT06720987